Using kidneys from donors who died of cardiovascular causes may help reduce disparities for black patients awaiting a kidney transplant, according to new research from Johns Hopkins Medical Institutions in Baltimore. Black patients with end-stage renal disease (ESRD) comprise more than a third of Americans currently on the kidney transplant waiting list but are 2.7 [Sign in to read the full article...]

Patients with hepatitis C who receive a liver from a donor older than 60 are not at  increased risk for transplant failure, death or recurrent disease within five years after transplantation, say researchers at the Washington University School of Medicine in St. Louis. They analyzed data from 489 adults who had liver transplants at the [Sign in to read the full article...]

Ninety-six percent of children who receive liver transplants from living relations live at least five years after surgery, according to new research published in the July issue of the British Journal of Surgery. The findings, from the Institute of Liver Studies at King’s College Hospital, London, are based on 50 living related liver transplants performed [Sign in to read the full article...]

Treatment with cholesterol-lowering “statin” drugs may lead to longer survival among kidney transplant recipients, according to a new study reported in the November issue of the Journal of the American Society of Nephrology. “Statin therapy is well established for the primary and secondary prevention of cardiovascular disease in the general population, but its effectiveness in [Sign in to read the full article...]

Scientists in Illinois and Pennsylvania have reported a way to produce an antifreeze protein used by billions of Canadian snow fleas to survive frigid winter temperatures. The laboratory-produced proteins could have practical use in extending the storage life of donor organs and tissues for human transplantation, the researchers indicate in the July 9 issue of [Sign in to read the full article...]